DOCKERY CARL
Transaction: 06/30/2025
OTHER
Change
0
Price
Not reported
Filing
10/20/2025
Type
OTHER
Aytu BioPharma, Inc.
AYTU • Drug Manufacturers - Specialty & Generic
$2.21
▼ -0.08 (-3.28%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$23.23M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 13, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.21
Change-3.28%
Shares Out10.51M
Market Cap$23.23M
Enterprise Value$18.53M
52W Range1.65 - 3.07
Beta0.25
P/E-0.68
P/S0.41
P/B0.66
P/FCF-17.13
EV/Sales0.33
Price$2.21
Change-3.28%
Shares Out10.51M
Market Cap$23.23M
Enterprise Value$18.53M
52W Range1.65 - 3.07
Beta0.25
P/E-0.68
P/S0.41
P/B0.66
P/FCF-17.13
EV/Sales0.33
EV/EBITDA-0.71
EV/FCF-13.67
Earnings Yield-146.60%
FCF Yield-5.84%
Dividend Yield0.00%
Gross Margin69.04%
Oper. Margin-11.79%
Profit Margin-20.43%
Debt/Eq1.21
Current Ratio1.26
Quick Ratio1.07
Volume7.34K
Avg Volume40.96K
EPS Surprise-0.22
Investment DNA
How strong this company looks for long-term investors
40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
54/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-09-05
100/100
Bullish
Bullish
5
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
Donofrio John Jr.
Transaction: 10/03/2025
BUY
Change
+10,000
Price
Not reported
Filing
10/07/2025
Type
BUY
DOCKERY CARL
Transaction: 10/03/2025
BUY
Change
+10,000
Price
Not reported
Filing
10/07/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| DOCKERY CARL | OTHER | 0 | Not reported | 06/30/2025 | 10/20/2025 |
| Donofrio John Jr. | BUY | +10,000 | Not reported | 10/03/2025 | 10/07/2025 |
| DOCKERY CARL | BUY | +10,000 | Not reported | 10/03/2025 | 10/07/2025 |
| JAIN ABHINAV | BUY | +10,000 | Not reported | 10/03/2025 | 10/07/2025 |
| LIU VIVIAN H | BUY | +10,000 | Not reported | 10/03/2025 | 10/07/2025 |
| Disbrow Joshua R. | BUY | +31,446 | Not reported | 10/03/2025 | 10/07/2025 |
| Selhorn Ryan J | BUY | +16,243 | Not reported | 10/03/2025 | 10/07/2025 |
| Disbrow Jarrett | BUY | +19,606 | Not reported | 10/03/2025 | 10/07/2025 |
| PYSZCZYMUKA GREG | BUY | +12,500 | Not reported | 10/03/2025 | 10/07/2025 |
| Disbrow Joshua R. | BUY | +66,666 | $1.50 | 06/09/2025 | 06/10/2025 |
| Disbrow Jarrett | BUY | +16,666 | $1.50 | 06/09/2025 | 06/10/2025 |
| Nantahala Capital Management, LLC | BUY | +4,000,000 | $0.00 | 06/06/2025 | 06/09/2025 |
| PYSZCZYMUKA GREG | SELL | -209 | Not reported | 03/31/2025 | 03/31/2025 |
| PYSZCZYMUKA GREG | BUY | +209 | Not reported | 03/31/2025 | 03/31/2025 |
| Disbrow Joshua R. | BUY | +15,000 | $1.30 | 02/28/2025 | 03/03/2025 |
| Selhorn Ryan J | SELL | -105 | Not reported | 02/05/2025 | 03/03/2025 |
| Selhorn Ryan J | BUY | +105 | Not reported | 02/05/2025 | 03/03/2025 |
| PYSZCZYMUKA GREG | SELL | -208 | Not reported | 12/31/2024 | 01/02/2025 |
| PYSZCZYMUKA GREG | BUY | +208 | Not reported | 12/31/2024 | 01/02/2025 |
| Selhorn Ryan J | OTHER | +105 | Not reported | 11/11/2024 | 11/13/2024 |